STEPHEN GRELECKI: Open Payments
NPI 1508838665 · ELIZABETH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 49 payments from 6 companies in 2025. Trend: 2023 $637 · 2024 $510 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $357 |
| E.R. Squibb & Sons, L.L.C. | 19 | $325 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Alkermes, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, COBENFY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, Qelbree.
Industry payments across NJ — which companies pay providers there.
